Illumina Agrees To Delay $8B Grail Deal During FTC Challenge

Law360 (April 1, 2021, 9:13 PM EDT) -- Illumina Inc. has agreed to delay closing its planned $8 billion acquisition of cancer detection firm Grail Inc. until as late as September while the Federal Trade Commission challenges the deal in D.C. federal court.

Illumina and Grail have agreed not to close the proposed transaction until at least Sept. 20 or after 11:59 p.m. on the second business day after the court rules on the FTC's move for a preliminary injunction blocking the merger, whichever comes first.

U.S. District Judge Rudolph Contreras on Wednesday signed a temporary restraining order that puts in place the timing agreement between the FTC and...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!